跳至主要内容
临床试验/jRCT1052230050
jRCT1052230050已完成不适用

Post-marketing observational study on the efficacy and safety of Neuroguidewire and Guide Catheter NV2 for the treatment of AVM embolization

Asahi Intecc Co., Ltd.0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
30
主要终点
The rate of successful delivery of the micro catheter to the targeted locaton in the neurovasculature (Y/N)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18age old over 至 No limit(—)

入选标准

  • Patients who have undergone endovascular treatment for cerebral arteriovenous malformations using CHIKAI guidewires or FUBUKI guiding catheters during the investigations period.
  • Patients who have given consent for the use of their medical information.

排除标准

  • Patients treated with unapproved medical devices.

结局指标

主要结局

The rate of successful delivery of the micro catheter to the targeted locaton in the neurovasculature (Y/N)

Definition of successful delivery; The microcatheter tip should be located in an anatomically desirable location int the vessel to be treated.

次要结局

未报告次要终点

研究者

相似试验